Caribou Biosciences (CRBU) Gains (Losses) on Sale of Assets & Investments (2022 - 2026)
Caribou Biosciences' Gains (Losses) on Sale of Assets & Investments was -$14,000 in Q3 2024, compared with -$4,000 a year earlier.
Powered by 
Analysis
Caribou Biosciences (CRBU) Gains (Losses) on Sale of Assets & Investments (2022 - 2026) Analysis & Trends
On a trailing twelve-month basis, Caribou Biosciences' Gains (Losses) on Sale of Assets & Investments was -$125,000 through Sep 30, 2024; for FY2023, it came in at -$6,000.
- In earlier years, Gains (Losses) on Sale of Assets & Investments was -$133,000 in FY2022, -$733,000 in FY2020 and $2.29 million in FY2019.
- Quarterly Gains (Losses) on Sale of Assets & Investments has moved between -$102,000 (Q2 2024) and $31,000 (Q3 2022) over five years.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gains on Sales (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | - |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | - |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | - |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | - |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | - |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | - |
| 10 | Caribou Biosciences | 44.30 Mn | -419.78 Mn | - | -9,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | -9,000.00 |
| Jun 30, 2026 | -48,000.00 |
| Mar 31, 2026 | -126,000.00 |
| Dec 31, 2025 | 10,000.00 |
| Sep 30, 2025 | 53,000.00 |
| Jun 30, 2025 | -127,000.00 |
| Mar 31, 2025 | -88,000.00 |
| Dec 31, 2024 | 341,000.00 |
| Sep 30, 2024 | -14,000.00 |
| Jun 30, 2024 | -102,000.00 |
| Dec 31, 2023 | -9,000.00 |
| Sep 30, 2023 | -4,000.00 |
| Jun 30, 2023 | 22,000.00 |
| Mar 31, 2023 | -15,000.00 |
| Dec 31, 2022 | -60,000.00 |
| Sep 30, 2022 | 31,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | -88,000.00 |
API Access
Caribou Biosciences Gains (Losses) on Sale of Assets & Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CRBU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-investment-income", "ticker": "CRBU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-investment-income&ticker=CRBU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();